Symbol="BVXV"
AssetType="Common Stock"
Name="BiondVax Pharmaceuticals Ltd ADR"
Description="BiondVax Pharmaceuticals Ltd., a development-stage biopharmaceutical company, focuses on developing, manufacturing and marketing products for the prevention and treatment of infectious and related diseases in Israel. The company is headquartered in Jerusalem, Israel."
CIK="1611747"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)"
Address="JERUSALEM BIOPARK, 2ND FLOOR, HADASSAH EIN KEREM CAMPUS, JERUSALEM, IL"
FiscalYearEnd="December"
LatestQuarter="2023-03-31"
MarketCapitalization="4597700"
EBITDA="-11066000"
PERatio="None"
PEGRatio="0"
BookValue="-1.465"
DividendPerShare="0"
DividendYield="0"
EPS="-4.03"
RevenuePerShareTTM="0"
ProfitMargin="0"
OperatingMarginTTM="0"
ReturnOnAssetsTTM="-0.274"
ReturnOnEquityTTM="-56.02"
RevenueTTM="0"
GrossProfitTTM="0"
DilutedEPSTTM="-4.03"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="0"
AnalystTargetPrice="39"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="-"
PriceToBookRatio="7.48"
EVToRevenue="-"
EVToEBITDA="-2.067"
Beta="2.463"
num_52WeekHigh="13.5"
num_52WeekLow="1.29"
num_50DayMovingAverage="1.676"
num_200DayMovingAverage="4.225"
SharesOutstanding="3284100"
DividendDate="None"
ExDividendDate="None"
symbol="BVXV"
open="1.38"
high="1.46"
low="1.37"
price="1.39"
volume="12835.00"
latest_trading_day="2023-07-06"
previous_close="1.39"
change="0.00"
change_percent="0.0000%"
aroon_positive_momentum_days="0"
aroon_negative_momentum_days="89"
trend_strength="Absent or Weak Trend"
buying_signal="Weak Sell Signal"
volume_analysis="Trending High"
value_analysis="Bullish Trend"
Aroon_change="FALSE"
Aroon_momentum="11"
Volume_recent_avg="110617"
Change_recent_avg="-0.02"
Delta_recent_avg="0.13"
Variance_recent_avg="0.06"
Change_ratio_recent_avg="-0.92"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="negative"
Aroon_change="FALSE"
Aroon_momentum_positive="11"
Aroon_momentum_negative="89"
image_negative_thumbnail_id_1="518"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0087.jpeg"
image_negative_thumbnail_id_2="1144"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0177.jpeg"
image_neutral_thumbnail_id_1="529"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0070.jpeg"
image_neutral_thumbnail_id_2="530"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0069.jpeg"
image_positive_thumbnail_id_1="999"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0161.jpeg"
image_positive_thumbnail_id_2="669"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0039.jpeg"
image_professor_thumbnail_id_1="1203"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0037.jpeg"
image_professor_thumbnail_id_2="1187"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0021.jpeg"
